Thu. 14 Mar 2024, 7:16am ET
Benzinga
Earnings, News
Cullinan Oncology (NASDAQ:CGEM) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.96) by 43.75 percent. This is a 40.66 percent increase over losses of $(0.91) per share from the same period last year.